These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8178059)

  • 1. [Allogenic reaction, a model of autoimmunity].
    Goldman M; Abramowicz D
    Rev Prat; 1994 Jan; 44(1):53-6. PubMed ID: 8178059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-DNA knock-in model of systemic autoimmunity induced by the chronic graft-vs-host reaction.
    Eisenberg R; Choudhury A
    Methods Mol Med; 2004; 102():273-84. PubMed ID: 15286390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TH2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity.
    Goldman M; Druet P; Gleichmann E
    Immunol Today; 1991 Jul; 12(7):223-7. PubMed ID: 1832281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential activation of Th2 cells in chronic graft-versus-host reaction.
    De Wit D; Van Mechelen M; Zanin C; Doutrelepont JM; Velu T; Gérard C; Abramowicz D; Scheerlinck JP; De Baetselier P; Urbain J
    J Immunol; 1993 Jan; 150(2):361-6. PubMed ID: 8419469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the pathogenic autoreactive T cells in cyclosporine-induced syngeneic graft-versus-host disease.
    Chen W; Thoburn C; Hess AD
    J Immunol; 1998 Dec; 161(12):7040-6. PubMed ID: 9862741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of the induction of autoimmune disease by graft-versus-host reaction. Role of CD8+ cells in the development of hepatic and ductal lesions induced by CD4+ cells in MHC class I plus II-different host.
    Suzuki K; Narita T; Yui R; Asakura H; Fujiwara M
    Lab Invest; 1994 May; 70(5):609-19. PubMed ID: 8196358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TH1 and TH2 dependent cytokines in experimental autoimmunity and immune reactions induced by chemicals.
    Dubey C; Bellon B; Druet P
    Eur Cytokine Netw; 1991; 2(3):147-52. PubMed ID: 1832570
    [No Abstract]   [Full Text] [Related]  

  • 8. Functional divergence of antigen-specific T-lymphocyte responses in syngeneic graft-versus-host disease.
    Thoburn CJ; Miura Y; Bright EC; Hess AD
    Biol Blood Marrow Transplant; 2004 Sep; 10(9):591-603. PubMed ID: 15319771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.
    Fowler DH; Breglio J; Nagel G; Eckhaus MA; Gress RE
    J Immunol; 1996 Dec; 157(11):4811-21. PubMed ID: 8943383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.
    Pelot MR; Pearson DA; Swenson K; Zhao G; Sachs J; Yang YG; Sykes M
    Biol Blood Marrow Transplant; 1999; 5(3):133-43. PubMed ID: 10392959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.
    Johnson BD; Becker EE; Truitt RL
    Biol Blood Marrow Transplant; 1999; 5(3):123-32. PubMed ID: 10392958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monitoring of graft versus host (GVH) reaction and host versus graft (HVG) reaction].
    Tanaka S; Orita K
    Nihon Rinsho; 1990 Sep; 48(9):2041-7. PubMed ID: 2232208
    [No Abstract]   [Full Text] [Related]  

  • 13. The nephritogenic T cell response in murine chronic graft-versus-host disease.
    Meyers CM; Tomaszewski JE; Glass JD; Chen CW
    J Immunol; 1998 Nov; 161(10):5321-30. PubMed ID: 9820505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autoimmune syndrome associated with host versus graft reaction in the mouse].
    Goldman M; Abramowicz D; Doutrelepont JM
    Nephrologie; 1989; 10(3):109-11. PubMed ID: 2691905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of host (endogenous) T cells in chronic graft-versus-host autoimmune disease.
    Chen F; Maldonado MA; Madaio M; Eisenberg RA
    J Immunol; 1998 Dec; 161(11):5880-5. PubMed ID: 9834067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of peripheral autoregulatory mechanisms that prevent development of cyclosporin-induced syngeneic graft-versus-host disease.
    Hess AD; Fischer AC; Horwitz L; Bright EC; Laulis MK
    J Immunol; 1994 Jul; 153(1):400-11. PubMed ID: 8207251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membranous nephropathy is developed under Th2 environment in chronic graft-versus-host disease.
    Nakashima H
    Med Hypotheses; 2007; 69(4):787-91. PubMed ID: 17398013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
    Johnson BD; Becker EE; LaBelle JL; Truitt RL
    J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
    Edinger M; Hoffmann P; Ermann J; Drago K; Fathman CG; Strober S; Negrin RS
    Nat Med; 2003 Sep; 9(9):1144-50. PubMed ID: 12925844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lupus-like autoimmunity in murine graft-versus-host disease.
    Portanova JP; Kotzin BL
    Concepts Immunopathol; 1988; 6():119-40. PubMed ID: 3292048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.